Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novoheart Holdings Inc. V.NVH

Healthcare Biotechnology
"Novoheart Holdings Inc is a Canadian based company. It is engaged in the engineering bio-artificial human heart tissues and chambers for drug discovery, cardiotoxicity screening, disease modeling and future therapeutic applications. Novoheart's scientific team has pioneered a range of bioengineering technologies collectively known as the MyHeart platform, including first human mini-heart... see more

Recent & Breaking News (TSXV:NVH)

IIROC Trading Resumption - NVH

Canada NewsWire June 6, 2019

Novoheart to Acquire Xellera Therapeutics

GlobeNewswire May 28, 2019

IIROC Trading Halt - NVH

Canada NewsWire May 27, 2019

Novoheart Holdings Inc. Reports Third Quarter 2019 Financial Results and Stock Option Grants

GlobeNewswire May 17, 2019

Novoheart Grants Stock Options

GlobeNewswire March 6, 2019

Novoheart Holdings Inc. Reports Second Quarter 2019 Financial Results and Announces AGM Results

GlobeNewswire March 1, 2019

Novoheart Grants Stock Options and RSUs

GlobeNewswire February 8, 2019

Novoheart Provides Corporate Update

GlobeNewswire January 7, 2019

Novoheart Holdings Inc. Reports First Quarter 2019 Financial Results

GlobeNewswire November 22, 2018

Novoheart to Generate USD $1.7m From Strategic Partnership to Build Good Manufacturing Practice Facility to Create Clinical-Grade Human Stem Cell Libraries

GlobeNewswire October 31, 2018

Novoheart Recruits Notable Pharma Industry Executive, Bernard Fermini, Ph.D. as Chief R&D Officer

GlobeNewswire September 24, 2018

Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2018 Financial Results

GlobeNewswire August 22, 2018

Novoheart Appoints Biotech Industry Specialist as New Senior Vice President to Lead Commercial Development

GlobeNewswire August 1, 2018

Novoheart Announces Presentation at the International Society for Stem Cell Research Annual Meeting

GlobeNewswire June 25, 2018

Novoheart Wins Coveted 2018 MedTech Breakthrough Award

GlobeNewswire June 13, 2018

Novoheart Receives C$400,000 in Research Funding from the Innovation and Technology Commission of Hong Kong

GlobeNewswire June 6, 2018

Novoheart Becomes Member of International Consortium Advancing Cardiac Safety in Drug Development

GlobeNewswire May 31, 2018

Novoheart Holdings Inc. Reports Third Quarter 2018 Financial Results

GlobeNewswire May 11, 2018

Novoheart to Debut New, State-of-the-art ‘Human Heart-in-a-Jar 2.0’ Technology at the 2018 International Society for Stem Cell Research (ISSCR) Annual Meeting

GlobeNewswire May 2, 2018

Novoheart Founder & CEO Dr. Ronald Li honored with 2017 Distinguished Alumnus Award by the University of Waterloo

GlobeNewswire April 12, 2018